| Market Cap | ₹58,021Cr |
| ROE | 14.23% |
| P/E Ratio(TTM) | 69.03 |
| EPS(TTM) | 15.57 |
| P/B Ratio | 12.07 |
| Dividend Yield | 0.11% |
| Industry P/E | 32.94 |
| Book Value | 89.01 |
| Debt to Equity | 0.46 |
| Face Value | 2 |
| Managing Director | Dr. Satyanarayana Chava |
| Founded | 2005 |
| NSE Symbol | LAURUSLABS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.07 | ||
| Cipla | NA (0.00%) | 24.01 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.45 | ||
| Lupin | NA (0.00%) | 22.53 |